{"id":556970,"date":"2026-06-22T22:10:47","date_gmt":"2026-06-22T20:10:47","guid":{"rendered":"https:\/\/medizinonline.com\/inducao-e-manutencao-da-remissao-com-produtos-biologicos-e-jak-i\/"},"modified":"2026-05-18T13:19:55","modified_gmt":"2026-05-18T11:19:55","slug":"inducao-e-manutencao-da-remissao-com-produtos-biologicos-e-jak-i","status":"publish","type":"post","link":"https:\/\/medizinonline.com\/pt-pt\/inducao-e-manutencao-da-remissao-com-produtos-biologicos-e-jak-i\/","title":{"rendered":"Indu\u00e7\u00e3o e manuten\u00e7\u00e3o da remiss\u00e3o com produtos biol\u00f3gicos e JAK-i"},"content":{"rendered":"\n<p class=\"wp-block-paragraph\"><strong>O objetivo terap\u00eautico mais importante para a colite ulcerosa \u00e9 a remiss\u00e3o cl\u00ednica e endosc\u00f3pica. Para a atividade moderada a grave da doen\u00e7a, est\u00e3o dispon\u00edveis v\u00e1rias op\u00e7\u00f5es para escalar o tratamento. Um estudo n\u00e3o intervencional examinou a op\u00e7\u00e3o de utilizar vedolizumab e tofacitinib ap\u00f3s a falha da terap\u00eautica anti-TNF\u03b1 e uma an\u00e1lise secund\u00e1ria recente analisou a utiliza\u00e7\u00e3o de inibidores da IL-23p19.    <\/strong><\/p>\n\n<div class=\"pmpro\"><div class=\"pmpro_card pmpro_content_message\"><div class=\"pmpro_card_content\">Dieser Inhalt ist nur f\u00fcr Benutzer der Gruppe: Medizinische Fachperson zug\u00e4nglich <br \/><a href=\"https:\/\/medizinonline.com\/pt-pt\/a-minha-conta\/pacotes\/\">Jetzt beitreten<\/a><\/div><div class=\"pmpro_card_actions pmpro_font-medium\">Already a member? <a href=\"https:\/\/medizinonline.com\/pt-pt\/iniciar-sessao\/?redirect_to=https%3A%2F%2Fmedizinonline.com%2Fpt-pt%2Finducao-e-manutencao-da-remissao-com-produtos-biologicos-e-jak-i%2F\">Log in here<\/a><\/div><\/div><\/div>","protected":false},"excerpt":{"rendered":"<p>O objetivo terap\u00eautico mais importante para a colite ulcerosa \u00e9 a remiss\u00e3o cl\u00ednica e endosc\u00f3pica. Para a atividade moderada a grave da doen\u00e7a, est\u00e3o dispon\u00edveis v\u00e1rias op\u00e7\u00f5es para escalar o&#8230;&hellip;... <\/p>\n<div class=\"pmpro\"><div class=\"pmpro_card pmpro_content_message\"><div class=\"pmpro_card_content\">Dieser Inhalt ist nur f\u00fcr Benutzer der Gruppe: Medizinische Fachperson zug\u00e4nglich <br \/><a href=\"https:\/\/medizinonline.com\/pt-pt\/a-minha-conta\/pacotes\/\">Jetzt beitreten<\/a><\/div><div class=\"pmpro_card_actions pmpro_font-medium\">Already a member? <a href=\"https:\/\/medizinonline.com\/pt-pt\/iniciar-sessao\/?redirect_to=https%3A%2F%2Fmedizinonline.com%2Fpt-pt%2Finducao-e-manutencao-da-remissao-com-produtos-biologicos-e-jak-i%2F\">Log in here<\/a><\/div><\/div><\/div>","protected":false},"author":7,"featured_media":556972,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"pmpro_default_level":"","cat_1_feature_home_top":false,"cat_2_editor_pick":false,"csco_eyebrow_text":"Colite ulcerosa: evid\u00eancias actuais sobre terapias anti-inflamat\u00f3rias  ","footnotes":"","_members_access_role":[],"_members_access_error":""},"category":[11551,11521,11407,11305,11529],"tags":[93858,12217,11806,15825,11644,93861,21666,93863,93864,65853,93859,93860,93862,21373,21391],"powerkit_post_featured":[],"class_list":["post-556970","post","type-post","status-publish","format-standard","has-post-thumbnail","category-rx-pt","category-estudos","category-gastroenterologia-e-hepatologia","category-medicina-interna-geral","category-relatorios-do-congresso","tag-anti-tnf","tag-biologicos","tag-ced-pt-pt","tag-colite-ulcerosa-pt-pt","tag-doenca-de-crohn","tag-escalonamento-da-terapia","tag-falha-terapeutica","tag-inducao-de-remissao","tag-inibidores-da-il-23p19","tag-jak-i-pt-pt","tag-manutencao-da-remissao","tag-remissao-clinica-e-endoscopica","tag-terapias-anti-inflamatorias","tag-tofacitinib-pt-pt","tag-vedolizumab-pt-pt","pmpro-level-required","pmpro-level-1","pmpro-no-access"],"acf":[],"publishpress_future_action":{"enabled":false,"date":"2026-09-05 04:56:49","action":"change-status","newStatus":"draft","terms":[],"taxonomy":"category","extraData":[]},"publishpress_future_workflow_manual_trigger":{"enabledWorkflows":[]},"wpml_current_locale":"pt_PT","wpml_translations":{"es_ES":{"locale":"es_ES","id":556966,"slug":"induccion-y-mantenimiento-de-la-remision-con-biologicos-y-jak-i","post_title":"Inducci\u00f3n y mantenimiento de la remisi\u00f3n con biol\u00f3gicos y JAK-i","href":"https:\/\/medizinonline.com\/es\/induccion-y-mantenimiento-de-la-remision-con-biologicos-y-jak-i\/"}},"_links":{"self":[{"href":"https:\/\/medizinonline.com\/pt-pt\/wp-json\/wp\/v2\/posts\/556970","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/medizinonline.com\/pt-pt\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/medizinonline.com\/pt-pt\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/medizinonline.com\/pt-pt\/wp-json\/wp\/v2\/users\/7"}],"replies":[{"embeddable":true,"href":"https:\/\/medizinonline.com\/pt-pt\/wp-json\/wp\/v2\/comments?post=556970"}],"version-history":[{"count":1,"href":"https:\/\/medizinonline.com\/pt-pt\/wp-json\/wp\/v2\/posts\/556970\/revisions"}],"predecessor-version":[{"id":556973,"href":"https:\/\/medizinonline.com\/pt-pt\/wp-json\/wp\/v2\/posts\/556970\/revisions\/556973"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/medizinonline.com\/pt-pt\/wp-json\/wp\/v2\/media\/556972"}],"wp:attachment":[{"href":"https:\/\/medizinonline.com\/pt-pt\/wp-json\/wp\/v2\/media?parent=556970"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/medizinonline.com\/pt-pt\/wp-json\/wp\/v2\/category?post=556970"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/medizinonline.com\/pt-pt\/wp-json\/wp\/v2\/tags?post=556970"},{"taxonomy":"powerkit_post_featured","embeddable":true,"href":"https:\/\/medizinonline.com\/pt-pt\/wp-json\/wp\/v2\/powerkit_post_featured?post=556970"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}